An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: A prospective anticancer

Related Experiment Video

Updated: May 9, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Claudine Neyen1, Subhankar Mukhopadhyay, Siamon Gordon

  • 1Sir William Dunn School of Pathology; University of Oxford; Oxford, UK.

Oncoimmunology
|July 30, 2013
PubMed

Insights

Tumor-associated macrophages promote cancer spread by expressing scavenger receptor A (SRA). Targeting SRA with the peptide 4F in vivo effectively prevented metastasis, showing 4F

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) often adopt an M2 phenotype.
  • M2-polarized TAMs express scavenger receptor A (SRA), contributing to tumor progression and metastasis.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting SRA in vivo.
  • To evaluate the efficacy of the small peptide inhibitor 4F in preventing cancer metastatic spread.

Main Methods:

  • In vivo studies utilizing the peptide inhibitor 4F.
  • Assessment of SRA targeting and its effect on metastatic spread.

Main Results:

  • Demonstrated successful in vivo therapeutic targeting of SRA.
  • The peptide inhibitor 4F effectively prevented tumor metastatic spread.

Conclusions:

  • Scavenger receptor A (SRA) is a viable therapeutic target in cancer.
  • The small peptide inhibitor 4F shows promise as an anticancer agent for preventing metastasis.
Keywords:
apo A-I mimetic peptideco-cultureligandscavenger receptortumor-associated macrophage

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...